AI across the Life Sciences lifecycle — from compliance to clinic to commercial.
Sutra brings AI to Quality, Manufacturing, and Regulatory operations. The places where small mistakes become expensive ones — measured in months of delay, batches lost, and patients waiting.
The risks that build up quietly — before anyone sees them.
- ●Compliance documentation that is too large and too scattered for anyone to navigate quickly. The answer is in there. The time to find it is not.
- ●Batch deviations discovered after the damage is done and the batch is already gone.
- ●Submissions filed with inconsistencies that only surface when the Complete Response Letter arrives.
- ●Clinical enrollment delays that quietly compound for months before anyone has early warning.
- ●Institutional knowledge that lives in a few experienced people's heads — and walks out the door when they leave.
Three products. One platform. The full development lifecycle covered.
Sutra agents watch your documentation, your manufacturing operations, and your regulatory lifecycle — surfacing risks, answering compliance questions on the spot, and giving your team the kind of visibility that used to live only in the experienced manager's head.
Whether you are in early development or commercial manufacturing, Sutra brings the right capability to the stage that matters most right now.
Cited answers from your own compliance documentation in seconds. Contradictions caught before inspectors do. The knowledge your team has built — finally searchable, auditable, and available to everyone.
Explore Sutra IntelligenceReal-time deviation detection, root cause correlation in minutes instead of days, and CAPA documentation that drafts itself from the data.
Explore Sutra ManufacturingConsistency checking across submission modules, enrollment risk picked up before timelines slip, and a regulatory audit trail that stays current on its own.
Explore Sutra RegulatoryWhat changes when Sutra is running.
Contradictions, gaps, and documentation issues surface before an inspector raises them.
Deviations caught early. A single recovered batch is worth $170,000 to $220,000.
Cross-module gaps spotted before filing. Complete Response Letter risk measurably reduced.
Eligible patients identified at a scale manual chart review cannot match. Recruitment challenges account for 37% of clinical trial delays. (Tufts CSDD, 2024)